These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25284038)

  • 21. Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity.
    Cao Z; Yu D; Fu S; Zhang G; Pan Y; Bao M; Tu J; Shang B; Guo P; Yang P; Zhou Q
    Toxicol Lett; 2013 Apr; 218(2):174-85. PubMed ID: 23376478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta.
    Rodriguez GC; Haisley C; Hurteau J; Moser TL; Whitaker R; Bast RC; Stack MS
    Gynecol Oncol; 2001 Feb; 80(2):245-53. PubMed ID: 11161867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
    Chen HH; Zhou HJ; Wu GD; Lou XE
    Pharmacology; 2004 May; 71(1):1-9. PubMed ID: 15051917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells.
    Auyeung KK; Woo PK; Law PC; Ko JK
    J Ethnopharmacol; 2012 Jun; 141(2):635-41. PubMed ID: 21864667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling galectin-1 as a novel therapeutic target for cancer.
    Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
    Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological role and prognostic significance of NAC1 in ovarian cancer.
    Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
    Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
    Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
    Tong L; Chen W; Wu J; Li H
    Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer.
    Chan JK; Blansit K; Kiet T; Sherman A; Wong G; Earle C; Bourguignon LY
    Gynecol Oncol; 2014 Mar; 132(3):739-44. PubMed ID: 24472409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
    Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
    Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pitfall in chemotherapy for ovarian cancer.
    Kamura T; Kim YT
    Yonsei Med J; 2002 Dec; 43(6):779-82. PubMed ID: 12497662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms.
    Chuffa LGA; Reiter RJ; Lupi LA
    Carcinogenesis; 2017 Oct; 38(10):945-952. PubMed ID: 28575150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-3 in urine of cancer patients: stage and tissue specificity.
    Balasubramanian K; Vasudevamurthy R; Venkateshaiah SU; Thomas A; Vishweshwara A; Dharmesh SM
    J Cancer Res Clin Oncol; 2009 Mar; 135(3):355-63. PubMed ID: 18836743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cold Atmospheric Plasma (CAP) and CAP-Stimulated Cell Culture Media Suppress Ovarian Cancer Cell Growth - A Putative Treatment Option in Ovarian Cancer Therapy.
    Koensgen D; Besic I; Gümbel D; Kaul A; Weiss M; Diesing K; Kramer A; Bekeschus S; Mustea A; Stope MB
    Anticancer Res; 2017 Dec; 37(12):6739-6744. PubMed ID: 29187451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the hallmarks of ovarian cancer: The big picture.
    Petrillo M; Nero C; Amadio G; Gallo D; Fagotti A; Scambia G
    Gynecol Oncol; 2016 Jul; 142(1):176-183. PubMed ID: 27058837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neo-vascularization-based therapeutic perspectives in advanced ovarian cancer.
    Bhardwaj V; Zhang X; Pandey V; Garg M
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188888. PubMed ID: 37001618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galectin-3 Inhibition in COVID-19.
    Reddy K; Nichol A; McAuley DF
    Am J Respir Crit Care Med; 2023 Jan; 207(2):118-120. PubMed ID: 36154818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.